FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluvoxamine maleate from Actavis Pharma, Inc. under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)